NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study

NCT01952587

CompletedNA

Sponsor: ANRS, Emerging Infectious Diseases

Conditions: Hiv Infection

Interventions: A peripheral blood sample

Countries: France

Short title : X-linked biological response to HIV sensing: the ANRS EP 53 study. Main outcome : To demonstrate that HIV-infected women carry the TLR7 c.32A\>T SNP at a higher frequency than uninfected women, arguing in favor of a role of impaired production of IFN-alpha by pDCs in the risk of becoming infected by HIV-1. Secondary outcome : To directly demonstrate at a single cell level that the TLR7 c.32A\>T SNP is responsible for a reduce production of IFN-alpha by pDCs after activation of TLR7 by HIV-1 RNA. Short abstract (public dissemination) : Male and female display some differences in how their immune system responds to pathogens. This could be related to hormonal or genetic factors located on the X chromosome. This project aims at characterizing X-linked factors that can influence the innate immune response to HIV-1.

Eligibility overview

Sex: FEMALE

Age: 18 Years to

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

1. Caucasian Female
2. HIV-1 infection (ELISA and western-blot tests)
3. HIV-infection through the sexual route before 50 years-old
4. Continuous antiretroviral therapy for more than 6 months
5. Plasma HIV-1 RNA \<50 copies/ml in the last 6 months
6. Age \>18-year old
7. Health insurance
8. Informed consent

Exclusion Criteria:

1. HIV-infection through vertical or parenteral routes
2. Chronic infectious disease, notably HCV infection (hepatitis C virus)
3. Acute infectious disease
4. Auto-immune disease
5. Absence of social security (health insurance)
6. Pregnant or breastfeeding woman
7. Incapable adult
Locations (1)
  • Toulouse, France